Does OPRELVEKIN Cause Myelosuppression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Myelosuppression have been filed in association with OPRELVEKIN. This represents 22.2% of all adverse event reports for OPRELVEKIN.
6
Reports of Myelosuppression with OPRELVEKIN
22.2%
of all OPRELVEKIN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Myelosuppression From OPRELVEKIN?
Of the 6 reports, 3 (50.0%) required hospitalization, and 2 (33.3%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OPRELVEKIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does OPRELVEKIN Cause?
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)